The Federal Institute for Drugs and Medical Devices (BfArM) has released important information regarding the pharmacovigilance of Voxzogo® (vosoritide).

The latest update pertains to a change in the administration syringe and needle, resulting in product administration now measured in Units (U) instead of mL. This change is aimed at enhancing the precision and accuracy of dosage administration.

BfArM, being the authority responsible for drug safety in Germany, would like to ensure that this vital information reaches all healthcare professionals directly. 

Read more here:

https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/EN/RHB/2023/rhb-voxzogo.html?nn=968840